Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe De Wals

Showing results (111-120 of 126) with videos related to

Pageof 13
Sort By:
Birth Defects Research. Part A, Clinical and Molecular Teratology|July 26, 2008
Spina bifida before and after folic acid fortification in CanadaPhilippe De Wals, Fassiatou Tairou, Margot I Van Allen, et al.
The New England Journal of Medicine|July 13, 2007
Reduction in neural-tube defects after folic acid fortification in CanadaPhilippe De Wals, Fassiatou Tairou, Margot I Van Allen, et al.
Journal of Clinical Microbiology|August 28, 2015
Comparison of Phenotypic and Genotypic Approaches to Capsule Typing of Neisseria meningitidis by Use of Invasive and Carriage Isolate CollectionsC Hal Jones, Naglaa Mohamed, Eduardo Rojas, et al.
Health and Quality of Life Outcomes|May 24, 2019
A DELPHI study on aspects of study design to overcome knowledge gaps on the burden of disease caused by serogroup B invasive meningococcal diseaseOle Marten, Florian Koerber, David Bloom, et al.
Vaccines|February 26, 2022
An Observational Study to Assess the Effectiveness of 4CMenB against Meningococcal Disease and Carriage and Gonorrhea in Adolescents in the Northern Territory, Australia-Study ProtocolHelen S Marshall, Prabha H Andraweera, James Ward, et al.
Expert Review of Vaccines|November 9, 2016
The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protectionRay Borrow, Pedro Alarcón, Josefina Carlos, et al.
Expert Review of Vaccines|December 12, 2018
The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populationsReinaldo Acevedo, Xilian Bai, Ray Borrow, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2022
Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, CanadaDanuta M Skowronski, Yossi Febriani, Manale Ouakki, et al.
The Journal of Infection|October 23, 2022
Meningococcal disease in North America: Updates from the Global Meningococcal InitiativeEdwin J Asturias, Xilian Bai, Julie A Bettinger, et al.
Vaccine|June 18, 2013
International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccinesCaitlin N Dodd, Silvana A Romio, Steven Black, et al.
Pageof 13

Showing results (111-120 of 126) with videos related to

Sort By:
Pageof 13
Birth Defects Research. Part A, Clinical and Molecular Teratology|July 26, 2008
Spina bifida before and after folic acid fortification in CanadaPhilippe De Wals, Fassiatou Tairou, Margot I Van Allen, et al.
The New England Journal of Medicine|July 13, 2007
Reduction in neural-tube defects after folic acid fortification in CanadaPhilippe De Wals, Fassiatou Tairou, Margot I Van Allen, et al.
Journal of Clinical Microbiology|August 28, 2015
Comparison of Phenotypic and Genotypic Approaches to Capsule Typing of Neisseria meningitidis by Use of Invasive and Carriage Isolate CollectionsC Hal Jones, Naglaa Mohamed, Eduardo Rojas, et al.
Health and Quality of Life Outcomes|May 24, 2019
A DELPHI study on aspects of study design to overcome knowledge gaps on the burden of disease caused by serogroup B invasive meningococcal diseaseOle Marten, Florian Koerber, David Bloom, et al.
Vaccines|February 26, 2022
An Observational Study to Assess the Effectiveness of 4CMenB against Meningococcal Disease and Carriage and Gonorrhea in Adolescents in the Northern Territory, Australia-Study ProtocolHelen S Marshall, Prabha H Andraweera, James Ward, et al.
Expert Review of Vaccines|November 9, 2016
The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protectionRay Borrow, Pedro Alarcón, Josefina Carlos, et al.
Expert Review of Vaccines|December 12, 2018
The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populationsReinaldo Acevedo, Xilian Bai, Ray Borrow, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2022
Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, CanadaDanuta M Skowronski, Yossi Febriani, Manale Ouakki, et al.
The Journal of Infection|October 23, 2022
Meningococcal disease in North America: Updates from the Global Meningococcal InitiativeEdwin J Asturias, Xilian Bai, Julie A Bettinger, et al.
Vaccine|June 18, 2013
International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccinesCaitlin N Dodd, Silvana A Romio, Steven Black, et al.
Pageof 13